DermTopic: Psoriasis

Filter Your Results

 

News

 

Two-Year Data: TREMFYA™ (guselkumab) Achieves Consistent R…

New longer-term data from the open-label extension of the VOYAGE 1 trial demonstrate consistent rates of skin clearance …

IPC, Others Call for Creation of Worldwide Psoriasis Databas…

A new report calls for the creation of a web-based Global Psoriasis Atlas (GPA) database that will document the prevalen…

Five-Year Data Show Sustained Efficacy, Safety for Cosentyx

Novartis’ IL-17 blocker Cosentyx® (secukinumab) maintains PASI 90 and PASI 100 response rates at five yea…

Lilly to Present New Data for Olumiant® and Taltz® at EADV

Eli Lilly and Company will present Phase 2 safety and efficacy data evaluating Olumiant® (baricitinib) for the …

Dermira Presents New Data on Late-Stage Programs at European…

Dermira, Inc. will present data from its glycopyrronium tosylate (formerly DRM04) and Cimzia (certolizumab pegol) Phase …

GBI Research: Global Dermatology Pipeline Will See Shift Tow…

The global dermatology pipeline, which currently comprises 850 products with a disclosed stage of development, is primar…

Psoriasis Severity Linked to Increased Risk of Death

The more surface area of the body covered by psoriasis, the greater the risk of death, according to a new analysis by re…

FDA Greenlights Humira Biosim Cyltezo for Multiple Inflammat…

The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim Pharmaceuticals, Inc.’s Cyltezo™, …

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.